Viewing Study NCT01217203


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-05-29 @ 10:23 AM
Study NCT ID: NCT01217203
Status: COMPLETED
Last Update Posted: 2014-02-28
First Post: 2010-10-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse
Sponsor: Innate Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Patients With Multiple Myeloma Experiencing a View
None First or Second Relapse View
Keywords: